Navigation Links
Zamansky & Associates LLC Investigates Affymax Inc. Over Its Recall of Omontys Due to Fatal Reactions
Date:2/26/2013

New York, New York (PRWEB) February 26, 2013

Zamansky & Associates LLC notifies all investors in Affymax Inc. (“Affymax”) that it is investigating the recall of Omontys, its anemia treatment for kidney dialysis patients due to reports of fatal reactions. On February 25, 2012, according to Bloomberg News, Affymax’s stock price fell as much as 87 percent after the recall to $2.97 per share, after it had gained 61 percent over the previous 12 months. This investigation concerns potential securities fraud or disclosure violations by Affymax, and its officers and directors, for disclosure failures relating to the fatal reactions which caused the recall.

According to the Notice issued to healthcare providers by Affymax and its marketing partner, the “use of OMONTYS may result in serious hypersensitivity reactions including anaphylaxis, which may be life-threatening or fatal,” and “to date, fatal reactions have been reported in approximately 0.02% of patients following the first dose of intravenous administration.” Reuters reported that the U.S. Food and Drug Administration on Sunday alerted healthcare providers about the recall, and said it had received 19 reports of anaphylaxis from dialysis centers in the United States.

The investigation by Zamansky & Associates LLC concerns whether Affymax knew and failed to disclose the frequency and/or severity of these reactions to Omontys, and the FDA’s response, while its stock price rose over the last year. “If Affymax’s officers and directors knew that its stock price was artificially inflated, and would likely collapse when this news was
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Michigan’s Exotic Automation & Supply to Exhibit at the 2013 Work Truck Show & Green Truck Summit
2. Parents Recommend Americord over CBR & Viacord
3. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
4. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
5. DuPont Tate & Lyle Bio Products Announces Winner of Zemea® Innovation Award
6. Industry Thought Leader to Present Transformational Opportunities for Industry Adoption of Advanced Analytics at 2013 HIMSS Annual Conference & Exhibition
7. Global Biopesticides Market Trends & Forecasts (2012 – 2017)
8. Neurovascular/Interventional Neurology Market: Global Trends & Competitive Analysis - 2017
9. Corporate Financial Planning Experts Gather at IE – Innovation Enterprise’s Financial Planning & Analysis for Pharma & Biotech Summit
10. Foot & Ankle Devices Market (2012 – 2017) By Product Type (External Fixation, Internal Fixation, Joint Replacement, Prosthesis, Bracing) - Global Trends & Competitive Analysis
11. The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... BioCentury,s NewsMakers in the Biotech Industry conference on ... the Millennium Broadway Hotel & Conference Center in ... can be accessed at www.meipharma.com . A replay will ...
(Date:9/18/2014)... Pennsylvanie, 18 septembre 2014 Mapi, ... en 1974, a été depuis 40 ans ... évaluations cliniques traditionnelles par des évaluations recentrées ... sur les impacts économiques des traitements. ... A cours d,une récente conférence ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 SeqLL ... Sequencing (tSMS™) technology, announced today the closing of ... investment, led by Genomic Diagnostic Technologies, will increase ... diagnostic applications. , Founded in March 2013 by ... Bioinformatics Analyst at Helicos BioSciences, SeqLL has continued ...
(Date:9/18/2014)... to weight loss and diabetes prevention, could actually hasten ... they do it in a surprising way: by changing ... the substantial population of bacteria residing in our intestines. ... humans, were published today in Nature . Among ... Institute,s Immunology Department, who led this research together with ...
Breaking Biology Technology:MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 31974 - 2014 - Mapi fête ses 40 ans 2SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2Gut bacteria, artificial sweeteners and glucose intolerance 2Gut bacteria, artificial sweeteners and glucose intolerance 3
... only once-daily inhaled corticosteroid inhaler ... approved for children as young as age 4, KENILWORTH, ... today that ASMANEX(R) TWISTHALER(R) 110,mcg (mometasone furoate inhalation powder) is ... treatment of asthma as,prophylactic therapy in patients four years of ...
... August 19 ChemAxon, a software,solutions provider for ... their cheminformatics toolkits, Marvin & JChem. As well ... IUPAC name import,support for OLE 2 format useful ... JChem is a software suite of application programming,interfaces ...
... microRNA Technology, Developed by Columbia University Medical Center, ... Clinical use Acquires CLIA-certified lab to Expedite Commercialization of its ... microRNA-based Tests, Expands Pipeline With Three Additional microRNA-based Cancer Tests in ... Development, REHOVOT, Israel and ...
Cached Biology Technology:Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 2Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 3Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 4Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 5Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 6Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 7Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 8ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration 2Rosetta Genomics Reports Second Quarter 2008 Financial Results 2Rosetta Genomics Reports Second Quarter 2008 Financial Results 3Rosetta Genomics Reports Second Quarter 2008 Financial Results 4Rosetta Genomics Reports Second Quarter 2008 Financial Results 5Rosetta Genomics Reports Second Quarter 2008 Financial Results 6Rosetta Genomics Reports Second Quarter 2008 Financial Results 7Rosetta Genomics Reports Second Quarter 2008 Financial Results 8Rosetta Genomics Reports Second Quarter 2008 Financial Results 9Rosetta Genomics Reports Second Quarter 2008 Financial Results 10Rosetta Genomics Reports Second Quarter 2008 Financial Results 11Rosetta Genomics Reports Second Quarter 2008 Financial Results 12
(Date:9/18/2014)... roaches of the fish world, are the ideal animal ... shape. They,ve moved from the ocean into tens of ... each time changing their skeleton to adapt to the ... populations of sticklebacks now have turned up one of ... a simple change in that gene,s regulation in a ...
(Date:9/18/2014)... protective tentacles of host anemones, but new research shows ... across the open ocean. Although the process of long-distance ... the first time that the high level exchange of ... Steve Simpson, Senior Lecturer in Marine Biology and Global ... the Australian Research Council Centre of Excellence for Coral ...
(Date:9/17/2014)... Institute for the Arts and Humanities has received a ... a two-year project, "The Boundaries of the Human in ... will support a wide-ranging series of events aimed at ... One involves artists and researchers who are exploring the ... idea of humanism, and the other involves the increasingly ...
Breaking Biology News(10 mins):Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3Mellon Foundation awards grant for major project in the humanities and sciences 2
... University of Florida study following the evolution of lice ... ago, a technology which enabled them to successfully migrate ... associate curator of mammals at the Florida Museum of ... modern humans to better understand human evolution and migration ...
... Calif.) Calling the results "extremely surprising," researchers from ... University report that methane gas concentrations in the Gulf ... months after a massive release occurred following the Deepwater ... study, led by oceanographers John Kessler of Texas A&M ...
... a significant step forward in understanding the atmosphere,s ... some other gases, except carbon dioxide. The issue ... studies suggesting the self-cleaning power of the atmosphere ... others suggest greater stability. And what researchers are ...
Cached Biology News:UF study of lice DNA shows humans first wore clothes 170,000 years ago 2UF study of lice DNA shows humans first wore clothes 170,000 years ago 3UCSB, Texas A&M scientists find methane gas concentrations have returned to near-normal levels 2NOAA-led team measures atmosphere's self-cleaning capacity 2NOAA-led team measures atmosphere's self-cleaning capacity 3
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Mouse monoclonal [SPM302] to BCAR1, prediluted ( Abpromise for all tested applications). entrezGeneID: 9564 SwissProtID: P56945...
...
p21 Ras Immunogen: Recombinant C-H-ras p21(val-12). Storage: 4 C...
Biology Products: